VistaGen Therapeutics
VistaGen Therapeutics is a biopharmaceutical company focused on developing innovative treatments for neuropsychiatric disorders using its proprietary nose-to-brain delivery platform. The company’s pipeline includes candidates such as Fasedienol (PH94B) for social anxiety disorder, Itruvone (PH10) for major depressive disorder, and AV-101 for various CNS indications. VistaGen aims to leverage its neurocircuitry expertise to address unmet mental health needs, partnering with academic and industry collaborators to advance clinical programs and expand access to novel therapies.
VistaGen Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biopharma, Neuroscience, MentalHealth, and DrugDevelopment.
VistaGen Therapeutics’ developer surface includes documentation, API reference, getting-started guide, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 2
Portal, sign-up, and the first successful call
Documentation 2
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API
Other 2
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.